Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in biotechnology 2022-12, Vol.78, p.102846-102846, Article 102846
Hauptverfasser:	Harcum, Sarah W, Kiss, Robert D
Format:	Artikel
Sprache:	eng
Schlagworte:	Biotechnology Pharmaceutical Preparations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	102846
container_issue
container_start_page	102846
container_title	Current opinion in biotechnology
container_volume	78
creator	Harcum, Sarah W Kiss, Robert D
description
doi_str_mv	10.1016/j.copbio.2022.102846
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2739068423</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S095816692200180X</els_id><sourcerecordid>2739068423</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-c4eab6ad7d7d45bbbcb0b7a947d3bd5c670d7122f6fa90ae5bef9a7be843d5ad3</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxoMo7uzqG4jk6KXHdHf63x4EWVZXWNCDnkMlqd7J0EnaJD3L3HwI8QF9EjP06FFyqJD66vtI_Qh5VbJtycr27X6r_CyN31asqvJT1fP2CdmUfTcUjFfDU7JhQ9MXZdsOF-Qyxj1jrKk79pxc1C3PHg3fkF-32iQfDEzUHzAcDD5e0y87CBYULsmo3MghCdXO-ck_HK9p2iGdwWm0RtEjQoj094-f1OEjtV7DZNKRajzg5GeLLtEsPVlYcMsIKi3BuAdqnPMHSMa7mO8UqIVzZzQ46Rfk2QhTxJfnekW-fbj9enNX3H_--Onm_X2h6rJMheIIsgXd5cMbKaWSTHYw8E7XUjeq7Zjuyqoa2xEGBthIHAfoJPa81g3o-oq8WX3n4L8vGJOwJiqcJnDolyiqrh5Y2_OqzlK-SlXwMQYcxRyMhXAUJRMnImIvViLiRESsRPLY63PCIi3qf0N_EWTBu1WA-Z95_0FEZdAp1CagSkJ78_-EP70hpOk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2739068423</pqid></control><display><type>article</type><title>Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Harcum, Sarah W ; Kiss, Robert D</creator><creatorcontrib>Harcum, Sarah W ; Kiss, Robert D</creatorcontrib><identifier>ISSN: 0958-1669</identifier><identifier>EISSN: 1879-0429</identifier><identifier>DOI: 10.1016/j.copbio.2022.102846</identifier><identifier>PMID: 36410154</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biotechnology ; Pharmaceutical Preparations</subject><ispartof>Current opinion in biotechnology, 2022-12, Vol.78, p.102846-102846, Article 102846</ispartof><rights>2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S095816692200180X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36410154$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harcum, Sarah W</creatorcontrib><creatorcontrib>Kiss, Robert D</creatorcontrib><title>Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field</title><title>Current opinion in biotechnology</title><addtitle>Curr Opin Biotechnol</addtitle><subject>Biotechnology</subject><subject>Pharmaceutical Preparations</subject><issn>0958-1669</issn><issn>1879-0429</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-KFDEQxoMo7uzqG4jk6KXHdHf63x4EWVZXWNCDnkMlqd7J0EnaJD3L3HwI8QF9EjP06FFyqJD66vtI_Qh5VbJtycr27X6r_CyN31asqvJT1fP2CdmUfTcUjFfDU7JhQ9MXZdsOF-Qyxj1jrKk79pxc1C3PHg3fkF-32iQfDEzUHzAcDD5e0y87CBYULsmo3MghCdXO-ck_HK9p2iGdwWm0RtEjQoj094-f1OEjtV7DZNKRajzg5GeLLtEsPVlYcMsIKi3BuAdqnPMHSMa7mO8UqIVzZzQ46Rfk2QhTxJfnekW-fbj9enNX3H_--Onm_X2h6rJMheIIsgXd5cMbKaWSTHYw8E7XUjeq7Zjuyqoa2xEGBthIHAfoJPa81g3o-oq8WX3n4L8vGJOwJiqcJnDolyiqrh5Y2_OqzlK-SlXwMQYcxRyMhXAUJRMnImIvViLiRESsRPLY63PCIi3qf0N_EWTBu1WA-Z95_0FEZdAp1CagSkJ78_-EP70hpOk</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Harcum, Sarah W</creator><creator>Kiss, Robert D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field</title><author>Harcum, Sarah W ; Kiss, Robert D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-c4eab6ad7d7d45bbbcb0b7a947d3bd5c670d7122f6fa90ae5bef9a7be843d5ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biotechnology</topic><topic>Pharmaceutical Preparations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harcum, Sarah W</creatorcontrib><creatorcontrib>Kiss, Robert D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harcum, Sarah W</au><au>Kiss, Robert D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field</atitle><jtitle>Current opinion in biotechnology</jtitle><addtitle>Curr Opin Biotechnol</addtitle><date>2022-12</date><risdate>2022</risdate><volume>78</volume><spage>102846</spage><epage>102846</epage><pages>102846-102846</pages><artnum>102846</artnum><issn>0958-1669</issn><eissn>1879-0429</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36410154</pmid><doi>10.1016/j.copbio.2022.102846</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0958-1669
ispartof	Current opinion in biotechnology, 2022-12, Vol.78, p.102846-102846, Article 102846
issn	0958-1669 1879-0429
language	eng
recordid	cdi_proquest_miscellaneous_2739068423
source	MEDLINE; Elsevier ScienceDirect Journals
subjects	Biotechnology Pharmaceutical Preparations
title	Editorial overview: Pharmaceutical biotechnology: the pandemic years — new modality development and biomanufacturing innovations in a maturing field
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A51%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20overview:%20Pharmaceutical%20biotechnology:%20the%20pandemic%20years%20%E2%80%94%20new%20modality%20development%20and%20biomanufacturing%20innovations%20in%20a%20maturing%20field&rft.jtitle=Current%20opinion%20in%20biotechnology&rft.au=Harcum,%20Sarah%20W&rft.date=2022-12&rft.volume=78&rft.spage=102846&rft.epage=102846&rft.pages=102846-102846&rft.artnum=102846&rft.issn=0958-1669&rft.eissn=1879-0429&rft_id=info:doi/10.1016/j.copbio.2022.102846&rft_dat=%3Cproquest_cross%3E2739068423%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2739068423&rft_id=info:pmid/36410154&rft_els_id=S095816692200180X&rfr_iscdi=true